Concord Wealth Partners Zoetis Inc. Transaction History
Concord Wealth Partners
- $673 Million
- Q2 2025
A detailed history of Concord Wealth Partners transactions in Zoetis Inc. stock. As of the latest transaction made, Concord Wealth Partners holds 408 shares of ZTS stock, worth $59,604. This represents 0.01% of its overall portfolio holdings.
Number of Shares
408
Previous 310
31.61%
Holding current value
$59,604
Previous $51,000
23.53%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding ZTS
# of Institutions
2,118Shares Held
430MCall Options Held
1.47MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA41.9MShares$6.12 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$2.88 Billion0.12% of portfolio
-
Morgan Stanley New York, NY17.7MShares$2.59 Billion0.19% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.32 Billion2.21% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $68.4B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...